Abstract
The class 1C antiarrhythmic agent flecainide is considered a first-line rhythm control option for atrial fibrillation (AF) in patients without LV dysfunction or coronary artery disease. However, due to its blockade of sodium channels, its use carries the risk of PR and QRS prolongation and life-
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
